Scientists at the University of Oxford, led by Professor Ahmed Ahmed, are designing OvarianVax, a vaccine which teaches the immune system to recognise and attack the earliest stages of ovarian cancer. The team will receive up to £600,000 for the study over the next three years to support lab research into the vaccine.
In this study, the CRUK-funded researchers will establish the targets for the vaccine. They will find out which proteins on the surface of early-stage ovarian cancer cells are most strongly recognised by the immune system and how effectively the vaccine kills mini-models of ovarian cancer called organoids.
If this research is successful, work will then begin on clinical trials of the vaccine. The hope is that in the future, women could be offered this vaccine to prevent ovarian cancer in the first place.
Read the full story on the MRC Weatherall Institute of Molecular Medicine (MRC WIMM) website.
more recommended stories
Multi-Cancer Early Detection Test Saves LivesA groundbreaking multi-cancer early detection test.
Breath Sensor for Chronic Kidney Disease DetectionIn a groundbreaking development, researchers have.
Vagus Nerve Stimulation for PTSD ReliefA pioneering clinical study from The.
Gut Microbiota Diet Score and Infertility: Surprising Link RevealedCan what you eat really impact.
Lung Cancer Outcomes Linked to PSG Genes in WomenResearchers at Memorial Sloan Kettering Cancer.
Osteoarthritis Genetic Targets Identified in Largest StudyIn a groundbreaking achievement, researchers have.
lncRNAs in Tumor Microenvironment Drive Cancer ProgressionThe tumor microenvironment (TME) is a.
Lyme Disease Symptoms: Why They Linger After TreatmentLyme disease symptoms that persist after.
Body Image in Young Women: Cultural Influences MatterA new international study led by.
Early Alzheimer’s Found Through Blood BiomarkersA new study published in Molecular.
Leave a Comment